Reactive oxygen species-induced molecular damage and its application in pathology

Pathology International

Volumn 49, Issue 2, 1999, Pages 91-102

  Toyokuni, Shinya ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

4 hydroxy 2 nonenal; 8 hydroxy 2' deoxyguanosine; Reactive oxygen species; Redox regulation; Transcription factor

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; FREE RADICAL; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

CARCINOGENESIS; CELL DAMAGE; COVALENT BOND; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; RADIATION INJURY; REPERFUSION INJURY; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; DNA DAMAGE; FREE RADICALS; HUMANS; IMMUNOENZYME TECHNIQUES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS;

EID: 0033041916     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00829.x     Document Type: Review

References (93)

1. 1 Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 2nd edn. Clarendon Press, Oxford, 1989.
2. 2 Fenton HJH. Oxidation of tartaric acid in presence of iron. J. Chem. Soc. 1894; 65: 899-910.
3. 3 McCord JM, Fridovich I. Superoxide dismulase: An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969; 244: 6049-6055.
4. 4 Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991; 51: 794-798.
5. 5 Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995; 358: 1-3.
6. 6 Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 1995; 18: 775-794.
7. 7 Dypbukt JM, Ankarcrona M, Burkitt M et al. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells: The role of intracellular polyamines. J. Biol. Chem. 1994; 269: 30 553-30 560.
8. 8 Sun Y, Oberley LW. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 1996; 21: 335-348.
9. 9 Ebina Y, Okada S, Hamazaki S, Ogino F, Li J-L, Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J. Natl Cancer Inst. 1986; 76: 107-113.
10. 10 Li J-L, Okada S, Hamazaki S, Ebina Y, Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res. 1987; 47: 1867-1869.
11. 11 Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn. J. Cancer Res. 1995; 86: 1150-1158.
12. 12 Okada S, Midorikawa O. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn. Arch. Intern. Med. 1982; 29: 485-491 (in Japanese with English abstract).
13. 13 Toyokuni S. Iron-induced carcinogenesis: The role of redox regulation. Free Radic. Biol. Med. 1996; 20: 553-566.
14. 14 Hamazaki S, Okada S, Ebina Y, Li J-L, Midorikawa O. Effect of dietary vitamin E on ferric nitrilotriacetate-induced nephrotoxicity in rats. Toxicol. Appl. Pharmacol. 1988; 92: 500-506.
15. 15 Toyokuni S, Okada S, Hamazaki S et al. Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res. 1990; 50: 5574-5580.
16. 7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic. Biol. Med. 1997; 22: 1019-1027.
17. 17 Halliwell B. Oxidative DNA damage: Meaning and measurement. In: Halliwell B, Aruoma OI, eds. DNA and Free Radicals. Ellis Horwood Ltd, Chichester, West Sussex, 1993; 67-79.
18. 18 Toyokuni S, Sagripanti J-L. Association between 8-hydroxy-2′-deoxyguanosine formation and DNA strand breaks mediated by copper and iron. Free Radic. Biol. Med. 1996; 20: 859-864.
19. 19 Toyokuni S, Mori T, Hiai H, Dizdaroglu M. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int. J. Cancer 1995; 62: 309-313.
20. 20 Toyokuni S, Mori T, Dizdaroglu M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int. J. Cancer 1994; 57: 123-128.
21. 21 Lillie RD, Fullmer HM. Histopathologic Technic and Practical Histochemistry. McGraw-Hill Book Company, New York, 1976.
22. 22 Pompella A, Maellaro E, Casini AF, Comporti M. Histochemical detection of lipid peroxidation in the liver of bromobenzene-poisoned mice. Am. J. Pathol. 1987; 129: 295-301.
23. 23 Pompella A, Comporti M. The use of 3-hydroxy-2-naphthoic acid hydrazide and Fast Blue B for the histochemical detection of lipid peroxidation in animal tissues: A microphotometric study. Histochemistry 1991; 95: 255-262.
24. 24 Pompella A, Comporti M. Imaging of oxidative stress at subcellular level by confocal laser scanning microscopy after fluorescent derivatization of cellular carbonyls. Am. J. Pathol. 1993; 142: 1353-1357.
25. 25 Tanaka T, Nishiyama Y, Okada K et al. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: Independence of tubular necrosis and sulfhydryl depletion. Lab. Invest. 1997; 77: 145-155.
26. 26 Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. J. Immunol. 1983; 130: 1910-1917.
27. 27 Hirai KI, Moriguchi K, Wang GY. Human neutrophils produce free radicals from the cell-zymosan interface during phagocytosis and from the whole plasma membrane when stimulated with calcium ionophore A23187. Exp. Cell Res. 1991; 194: 19-27.
28. 3. Blood 1982; 60: 1195-1202.
29. 29 Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl Acad. Sci. USA 1994; 91: 2616-2620.
30. 30 Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab. Invest. 1997; 76: 365-374.
31. 31 Esterbauer H, Benedetti H, Lang J, Fulceri R, Fauler G, Comporti M. Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochem. Biophys. Acta 1986; 876: 154-166.
32. 32 Esterbauer H, Schauur JS, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991; 11: 81-128.
33. 33 Grune T, Siems WG, Zollner H, Esterbauer H. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages. Cancer Res. 1994; 54: 5231-5235.
34. 34 Uchida K, Stadtman ER. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl Acad. Sci. USA 1992; 89: 4544-4548.
35. 35 Uchida K, Szweda LI, Chae H-Z, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl Acad. Sci. USA 1993; 90: 8742-8746.
36. 36 Toyokuni S, Miyake N, Hiai H et al. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 1995; 359: 189-191.
37. 37 Luna LG. Manual of Histological Staining Methods of the Armed Forces Institute of Pathology, 3rd edn. McGraw-Hill, New York, 1968.
38. 38 Okamoto K, Toyokuni S, Uchida K et al. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal cell carcinoma. Int. J. Cancer 1994; 58: 825-829.
39. 39 Uchida K, Itakura K, Kawakishi S, Hiai H, Toyokuni S, Stadtman ER. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 1995; 324: 241-248.
40. 40 Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 1996; 93: 2696-2701.
41. 41 Ando Y, Nyhlin N, Suhr O et al. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem. Biophys. Res. Commun. 1997; 232: 497-502.
42. 42 Ma Y, Zhang D, Kawabata T et al. Copper and iron-induced oxidative damage in non-tumor bearing LEC rats. Pathol. Int. 1997; 47: 203-208.
43. 43 Ohhira M, Ohtake T, Matsumoto A et al. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases. Alcohol. Clin. Exp. Res. 1997; 22: S145-S149.
44. 44 Kageyama F, Kobayashi Y, Koide S et al. Enhanced lipid peroxidation in chronic hepatitis C. Jpn. Pharmacol. Ther. 1998; 26: S405-S408.
45. 45 Pompella A, Cambiaggi C, Dominici S, Paolicchi A, Tongiani R, Comporti M. Single-cell investigation by laser scanning confocal microscopy of cytochemical alterations resulting from extracellular oxidant challenge. Histochem. Cell. Biol. 1996; 105: 173-178.
46. 46 Waeg G, Dimsity G, Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic. Res. 1996; 25: 149-159.
47. 47 Grune T, Reinheckel T, Davies KJA. Degradation of oxidized proteins in mammalian cells. FASEB J. 1997; 11: 526-534.
48. 48 Uchida K, Fukuda A, Kawakishi S, Hiai H, Toyokuni S. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch. Biochem. Biophys. 1995; 317: 405-411.
49. 49 Chaudhary AK, Nokubo M, Reddy GR et al. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science 1994; 265: 1580-1582.
50. 2-Ethenodeoxyguanosine as a potential marker for DNA adduct formation by trans-4-hydroxy-2-nonenal. Cancer Res. 1988; 48: 320-323.
51. 51 Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 1984; 12: 2137-2145.
52. 52 Devasagayam TPA, Steenken S, Obendorf MSW, Schultz WA, Sies H. Formation of 8-hydroxy (deoxy) guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen. Biochemistry 1991; 30: 6283-6289.
53. 53 Kasai H, Yamaizumi Z, Berger M, Cadet J. Photosensitized formation of 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-hydroxy-2′-deoxyguanosine) in DNA by riboflavin: A non singlet oxygen mediated reaction. J. Am. Chem. Soc. 1992; 114: 9692-9694.
54. 54 Inoue S, Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and Superoxide. FEBS Lett. 1995; 371: 86-88.
55. 55 Floyd RA. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990; 11: 1447-1450.
56. 56 Floyd RA, Watson JJ, Wong PK, Altmiller DH, Rickard RC. Hydroxyl free radical adducts of deoxyguanosine: Sensitive detection and mechanisms of formation. Free Radic. Res. Commun. 1986; 1: 163-172.
57. 57 Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991; 349: 431-434.
58. 58 Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G to T and A to C substitutions. J. Biol. Chem. 1992; 267: 166-172.
59. 59 Wood ML, Dizdaroglu M, Gajewski E, Essigmann JM. Mechanistic studies of ionizing radiation and oxidative mutagenesis: Genetic effect of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry 1990; 29: 7024-7032.
60. 60 Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993; 362: 709-715.
61. 61 Claycamp HG. Phenol sensitization of DNA to subsequent oxidative damage in 8-hydroxyguanine assays. Carcinogenesis 1992; 13: 1289-1292.
62. 62 Cadet J, Ravanat JL, Douki T. Artifacts associated with the measurement of oxidized DNA bases. Environ. Health Perspect. 1997; 105: 1034-1039.
63. 63 Sakumi K, Furuichi M, Tsuzuki T et al. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J. Biol. Chem. 1993; 268: 23 524-23 530.
64. 64 Slupska MM, Baikalov C, Luther WM, Chiang JH, Wei YF, Miller JH. Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J. Bacteriol. 1996; 178: 3885-3892.
65. 65 Aburatani H, Hippo Y, Ishida T et al. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res. 1997; 57: 2151-2156.
66. 66 Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 1997; 94: 8010-8015.
67. 67 Dizdaroglu M. Chemical determination of free radical-induced damage to DNA. Free Radic. Biol. Med. 1991; 10: 225-242.
68. 32P postlabeling. Anal. Biochem. 1992; 201: 127-133.
69. 69 Degan P, Shigenaga MK, Park E-M, Alperin PE, Ames BN. Immunoaffinity isolation of urinary 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2′-deoxyguanosine in DNA by polyclonal antibodies. Carcinogenesis 1991; 12: 865-871.
70. 70 Musarrat J, Wani AA. Quantitative immunoanalysis of promutagenic 8-hydroxy-2′-deoxyguanosine in oxidized DNA. Carcinogenesis 1994; 15: 2037-2043.
71. 71 Park EM, Shigenaga MK, Degan P et al. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc. Natl Acad. Sci. USA. 1992; 89: 3375-3379.
72. 72 Yin B, Whyatt RM, Perera FP, Randall MC, Cooper TB, Santella RM. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic. Biol. Med. 1996; 18: 1023-1032.
73. 73 Yarborough A, Zhang YJ, Hsu TM, Santella RM. Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res. 1996; 56: 683-688.
74. 74 Bruskov VI, Gaziev AI, Malakhova LV, Mantsygin IuA, Morenkov OS. Monoclonal antibodies to 8-oxo-2′-deoxyguanosine (8-hydroxyguanosine). Characteristics and use for determining DNA damage by active forms of oxygen. Biokhimiia 1996; 61: 737-744 (in Russian with English abstract).
75. 75 Osawa T, Yoshida A, Kawakishi S, Yamashita K, Ochi H. Protective role of dietary antioxidants in oxidative stress. In: Cutler RG, Packer L, Bertram J, Mori A, eds. Oxidative Stress and Aging. Berkhauser-Verlag, Basel, 1995; 367-377.
76. 76 Hattori Y, Nishigori C, Tanaka T et al. 8-Hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic UVB exposure. J. Invest. Dermatol. 1996; 107: 733-737.
77. 77 Takahashi S, Horose M, Tamano S et al. Immunohistochemical detection of 8-hydroxy-2′-deoxyguanosine in paraffin-embedded sections of rat liver after carbon tetrachloride treatment. Toxicol. Pathol. 1998; 26: 247-252.
78. 78 Nakae D, Mizumoto Y, Kobayashi E, Noguchi O, Konishi Y. Improved genomic/nuclear DNA extraction for 8-hydroxy-deoxyguanosine analysis of small amounts of rat liver tissue. Cancer Lett. 1995; 97: 233-239.
79. 79 Helbock HJ, Beckman KB, Shigenaga MK et al. DNA oxidation matters: The HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc. Natl Acad. Sci. USA 1998; 95: 288-293.
80. 80 Irani K, Xia Y, Zweier JL et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 1649-1652.
81. 81 Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
82. 82 Monteiro HP, Stern A. Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radic. Biol. Med. 1996; 21: 323-333.
83. 83 Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 1997; 22: 269-285.
84. 84 Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J. 1998; 11: 118-124.
85. 85 Zheng M, Aslund F, Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 1998; 279: 1718-1721.
86. 86 Ames BN, Shigenaga MK, Park E-M. DNA damage by endogenous oxidants as a cause of aging and cancer. In: Davies KJA, ed. Oxidative Damage and Repair: Chemical, Biological and Medical Aspects. Pergamon Press, New York, 1991; 181-187.
87. 87 Cutler RG. Antioxidants, aging, and longevity. In: Pryor WA, ed. Free Radicals in Biology. Academic Press, New York, 1984; 371-428.
88. 88 Toyokuni S, Tanaka T, Nishiyama Y et al. Induction of renal cell carcinoma in male Wistar rats treated with cupric nitrilotriacetate. Lab. Invest. 1996; 75: 239-248.
89. 89 Toyokuni S, Okada K, Kondo S et al. Development of high-grade renal cell carcinomas in rats independent of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Jpn. J. Cancer Res. 1998; 89: 814-820.
90. 90 Fukuda A, Osawa T, Oda H, Toyokuni S, Satoh K, Uchida K. Oxidative stress response in iron-induced renal carcinogenesis: Acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme. Arch. Biochem. Biophys. 1996; 329: 39-46.
91. 91 Tanaka T, Nishiyama Y, Okada K et al. Over-expression of glutathione S-transferase Yp isozyme and concomitant down-regulation of Ya isozyme in renal cell carcinoma of rats induced by ferric nitrilotriacetate. Carcinogenesis 1998; 19: 897-903.
92. 92 Nishiyama Y, Tanaka T, Naitoh H et al. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate. Jpn. J. Cancer Res. 1997; 88: 120-128.
93. 93 Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 1997; 387: 147-163.